News Search

In clinical trials, two new drugs slowed the loss of lung function in patients with a fatal lung disease, idiopathic pulmonary fibrosis.

Recent research at Columbia has shed light on an important risk marker for Alzheimer’s—"white matter hyperintensities" (WMH).

In an interview conducted by the Columbia Record, Dr. Taylor discussed the challenges for women in academic medicine today, her personal experiences, and the creation of the Virginia Kneeland Frantz Society for Women Faculty at P&S.